New process for the production of oxabispidines

Details for Australian Patent Application No. 2001292504 (hide)

Owner AstraZeneca AB

Inventors Pavey, John

Agent Davies Collison Cave

Pub. Number AU-B-2001292504

PCT Pub. Number WO02/28864

Priority SE00/01994 13.10.00 WO; 1-2000-02701 02.10.00 PH

Filing date 1 October 2001

Wipo publication date 15 April 2002

Acceptance publication date 7 September 2006

International Classifications

C07D 498/08 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

7 September 2006 Application Accepted

  Published as AU-B-2001292504

24 May 2007 Standard Patent Sealed

28 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001292505-A WATER TREATMENT TANK WITH A RETAINING APPARATUS FOR A MANIFOLD WITHIN THE TANK

2001292503-New oxabispidine compound useful in the treatment of cardiac arrhythmias